Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects

Documenti analoghi

• Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects
  di: Dieye, Tandakha N., et al.
  Pubblicazione: (2013)
• HIV-1 Genetic Diversity and Drug Resistance among Senegalese Patients in the Public Health System
  di: Thiam, Moussa, et al.
  Pubblicazione: (2013)
• High HIV-1 Virological Failure and Drug Resistance among Adult Patients Receiving First-Line ART for At least 12 Months at a Decentralized Urban HIV Clinic Setting in Senegal before the Test-and-Treat
  di: Ekollo Mbange, Aristid, et al.
  Pubblicazione: (2021)
• CD4 T-Cell Enumeration in a Field Setting: Evaluation of CyFlow Counter Using the CD4 Easy Count Kit-Dry and Pima CD4 Systems
  di: Wade, Djibril, et al.
  Pubblicazione: (2013)
• Sensitivity of IFN-γ Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression
  di: Karam, Farba, et al.
  Pubblicazione: (2008)